Stocks
Astellas Pharma Inc.

Astellas Pharma Inc.ALPMY

PNKHealthcareBiotechnology$14.18-0.74%

Price as of · delayed, not real-time

A global pharmaceutical company focused on developing and commercializing innovative therapies, particularly in oncology, urology, and immunology. With a robust pipeline and strategic partnerships, it is a key player in addressing unmet medical needs, making it a notable stock for healthcare investors.

Market Cap: $26.3B52W Range: $10.03-$17.35

Congressional Interest in Astellas Pharma Inc. (ALPMY)

6 members of Congress have disclosed 22 trades in Astellas Pharma Inc. (ALPMY), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
22
Unique Politicians
6
Buys
13
Sells
9

Who in Congress Is Trading ALPMY?

2023-07-10$15K-$50K
Stock
2023-02-27$15K-$50K
Stock
2023-01-13$1K-$15K
Stock
2020-03-18$15K-$50K
Stock
2018-11-19$1K-$15K
Stock
2018-08-09$1K-$15K
Stock
2018-07-10$1K-$15K
Stock
2018-06-01$1K-$15K
Stock
2018-03-26$1K-$15K
Stock
2017-07-31$1K-$15K
Stock
2017-05-26$1K-$15K
Stock
2017-05-25$15K-$50K
Stock
2017-05-10$15K-$50K
Stock
2017-01-10$1K-$15K
Stock
2017-01-09$15K-$50K
Stock
2016-12-07$15K-$50K
Stock
2016-09-20$1K-$15K
Stock
2016-07-27$1K-$15K
Stock
2016-07-26$15K-$50K
Stock
2015-03-31$1K-$15K
Stock
2012-01-10$1K-$15K
Stock
2012-01-10$1K-$15K
Stock